The results of 12 cancers showed that XCL2 is primarily associated with the biological function of T lymphocytes, including T cell polarization, PD-1 blockade, differentiation, chemotaxis, and multiple pathways of T cell-associated inflammatory factors such as IL12, IL23, STAT4, CD8, and TCR pathways. Here, CD8A is linked to cancer.